Drug Companies Told to Stockpile for U.K. "No-Deal" Brexit Scenario
Drug Companies Told to Stockpile for U.K. "No-Deal" Brexit Scenario
GALWAY, IRELAND--September 10, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pharmaceutical companies in the U.K. have been told that they must start stockpiling drugs in case the U.K. government fails to agree a suitable export deal as part of its difficult Brexit negotiations with the European Union (EU).
Within this article: Details contingency plans to medicine and device shortages related to Brexit, reaction from industry, pharma investment
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects